Mayo joint venture looks for new uses for drug molecules

  A new venture between the Mayo Clinic and a Boston-area artificial intelligence firm will work with drug companies to discover whether molecules researched for treatment of one disease can effectively treat other conditions. The month-old research company is called Qrativ and will target conditions for which current treatments are lacking. Mayo’s partner in the joint venture is Cambridge-based Nference.


Link to Full Article: Mayo joint venture looks for new uses for drug molecules

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about homeAI.info and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!